UBS AM
DTIL icon

UBS AM’s Precision BioSciences DTIL Stock Holding History

UBS AM’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,678
Closed -$155K – 2713
2022
Q1 		$155K Hold
1,678
– – ﹤0.01% 2707
2021
Q4 		$373K Hold
1,678
– – ﹤0.01% 2634
2021
Q3 		$581K Sell
1,678
-111
-6% -$37.6K ﹤0.01% 2434
2021
Q2 		$672K Buy
1,789
+249
+16% +$74.8K ﹤0.01% 2415
2021
Q1 		$478K Buy
1,540
+413
+37% +$145K ﹤0.01% 2406
2020
Q4 		$282K Buy
1,127
+250
+29% +$61.3K ﹤0.01% 2426
2020
Q3 		$162K Hold
877
– – ﹤0.01% 2427
2020
Q2 		$219K Buy
+877
New +$192K ﹤0.01% 2365

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS AM's DTIL Position: Q2 2022 in Review

UBS AM sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 1,678 shares — an estimated $155K sold.

UBS AM first reported a position in DTIL in Q2 2020 and held it in 8 quarters. The position peaked at $672K in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • UBS AM reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • UBS AM sold 1,678 Precision BioSciences shares in Q2 2022, an estimated $155K.
  • UBS AM first reported a position in Precision BioSciences in Q2 2020 and held it in 8 quarters.
  • UBS AM's Precision BioSciences position peaked at $672K in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.